PHARMA CITE
Board
2 directors, since incorporationDirector
appointed by deed of 28-11-2024
term without a fixed end
also on the board of 3 other companies
Director
appointed by deed of 28-11-2024
term without a fixed end
also on the board of 3 other companies
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 28-11-2024
Mandates through the years
2 names, the dashed line is todayBoard
Mandates as a list
- JAUMAIN Bénédicte Albertine Jacqueline Ghislaine
- Director, appointed by deed of 28-11-2024, still in office
- ROUCOUR Bruno Roger André
- Director, appointed by deed of 28-11-2024, still in office
Control
Founders
ROUCOUR Bruno Roger André, JAUMAIN Bénédicte Albertine Jacqueline Ghislaine
This company
PHARMA CITE
Equity -€10,995
Loss €10,995 in 2025
Capital
- Contribution
- €3,000
- Shares
- 100
- Contribution per share
- €30
- Equity per share
- -€110 in 2025
- Source
- deed of 28-11-2024
Articles of association
deed of 28-11-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant moitié acquéreurs proportionnellement si plusieurs, chacun des actionnaires”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Saturday of May at 20:00
Shareholders
At incorporation
deed of 28-11-2024 ↗
- ROUCOUR Bruno Roger André 50 shares (50%) · €1,500
- JAUMAIN Bénédicte Albertine Jacqueline Ghislaine 50 shares (50%) · €1,500